$MVIS

MicroVision's IRIS long-range lidar sensor has been chosen for integration into autonomous ground vehicle systems for defense applications. The selection follows an evaluation for high-performance perception in challenging environments. MicroVision's CEO highlighted the validation of IRIS's capabilities in demanding defense settings. The company continues to expand in security & defense, industrial, and automotive markets.

MicroVision (MVIS) announced its IRIS long-range lidar will support an autonomous mobility service pilot in the Asia-Pacific region. The technology integrates with cameras and radar for real-time environmental sensing. CEO Glen DeVos highlighted the progression from evaluation to real-world deployment, emphasizing the value of the Luminar assets acquisition. The program may transition to MicroVision's next-generation HALO sensor as it scales.

MicroVision (NASDAQ: MVIS) granted 674,536 and 562,114 restricted stock units to its new Chief Commercial Officer and Chief Financial Officer, respectively. The units vest over four years, contingent on continued service. The grants were made under the company's 2025 Inducement Equity Incentive Plan.

MicroVision (NASDAQ: MVIS) granted 674,536 RSUs to its new Chief Commercial Officer and 562,114 RSUs to its new CFO. The RSUs vest over four years, subject to continued service.

MicroVision (MVIS) stock rose 11% after announcing a partnership with an unnamed industrial equipment manufacturer to develop lidar technologies. The agreement involves installing Iris lidar sensors on off-highway trucks, with potential for further integration. Financial details were not disclosed. MVIS has underperformed, down 55% YTD and 70% over 12 months.

Fulcrum Therapeutics (FULC) fell 51% to a 52-week low of $2.9 after halting development of its lead sickle cell disease treatment due to FDA cancer risk concerns. Heron Therapeutics (HRTX) dropped 45% to $0.44 following a court ruling invalidating key patents for CINVANTI. MicroVision (MVIS) declined 32% to $0.4 after proposing a reverse stock split to meet Nasdaq requirements.

MicroVision (MVIS) announced multiple orders for its IRIS lidar sensors from customers in North America and Europe, totaling thousands of units. The orders span industrial, security, and defense applications, indicating commercial adoption. CEO Glen DeVos highlighted the orders as a bridge to the company's next-gen HALO lidar platform, expected to begin customer migrations in late 2027-2028.

MicroVision (MVIS) reported thousands of IRIS sensor orders from customers in North America and Europe for industrial, security, and defense applications, indicating commercial validation and near-term deployments. Deliveries will support current production, with migrations to the HALO platform expected from late-2027 to 2028. The stock rose 4.82% following the announcement.

MicroVision (MVIS) shares fell over 20% after D. Boral Capital downgraded the stock to 'Hold' from 'Buy', citing Q4 revenue decline of 88% YoY to $0.2M and wider-than-expected loss per share of $0.12. The analyst cited revenue uncertainty and lack of near-term growth clarity. The company's cash position is $74.8M, with $43M in convertible notes issued in February 2026.

MICROVISION, INC. (MVIS) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 MicroVision Announces Launch of Proposed Public Offering REDMOND, Wash., Aug. 13, 2026 – MicroVision, Inc. (NASDAQ: MVIS) (“MicroVision” or “Company”), a leader in advanced perception solutions for industrial, security and defense, and automotive applications, today